Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Dermatology

Free Subscription 23.02.2026 7 Am J Dermatopathol 1 Am J Ophthalmol 1 BMC Cancer 11 Br J Dermatol 2 Cancer 3 Cancer Lett 4 Cancer Res 1 Clin Exp Dermatol 2 Int J Dermatol 1 Intern Med 1 J Cutan Pathol 6 J Dermatol 1 Mycoses 1 N Engl J Med 1 PLoS Comput Biol 5 PLoS One 3 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Dermatopathol

1. BRAAT J, Holic LJ, Trichy NS, Olivares S, et al
   Immunophenotypic and Molecular Analysis of a Novel Case of ACTG1::MITF Fusion Clear Cell Tumor With Melanocytic Differentiation.
   Am J Dermatopathol. 2026;48:236-241.
   PubMed         Abstract available
   
   
2. KELLY JH, Meide EVH, Tjarks BJ
   Cutaneous Manifestation of Metastatic Papillary Thyroid Carcinoma.
   Am J Dermatopathol. 2026;48:233-235.
   PubMed         Abstract available
   
   
3. KISZLUK A, Alhalaseh YN, Asar MC, Chen F, et al
   Verhoeff-van Gieson May Distinguish Desmoplastic Melanoma From Re-Excision Scar.
   Am J Dermatopathol. 2026;48:193-196.
   PubMed         Abstract available
   
   
4. MILAM EC, Gottesman SP, Shaigany S
   Not So Normal Skin: A Review of the "Random" Skin Biopsy.
   Am J Dermatopathol. 2026;48:167-177.
   PubMed         Abstract available
   
   
5. HU AY, Wang X, Jorgensen J, Nagarajan P, et al
   NPM1 -Mutated Myeloid Sarcoma/Leukemia Cutis Mimicking Blastic Plasmacytoid Dendritic Cell Neoplasm and Heralding Bone Marrow Acute Myeloid Leukemia.
   Am J Dermatopathol. 2026;48:221-225.
   PubMed         Abstract available
   
   
6. FLIORENT R, Hoffman P, Onel KB, Magro C, et al
   Subcutaneous Granuloma Annulare: A Rare Case Associated With Acetazolamide.
   Am J Dermatopathol. 2026;48:216-220.
   PubMed         Abstract available
   
   
7. DEAN MA, Abdat RK, Yan S, Sriharan A, et al
   Plaque-Type Syringoma Mimicking Microcystic Adnexal Carcinoma in a Patient With Generalized Syringomas: Case Report and Review of Diagnostic Pitfalls in the Assessment of Unusual Syringomatous Proliferations.
   Am J Dermatopathol. 2026;48:226-229.
   PubMed         Abstract available
   
   

   
   Am J Ophthalmol

8. JIA H, Cai R, Liu L, Zhang J, et al
   Mismatch Repair Deficiency in Benign and Atypical Ocular Sebaceous Neoplasms: Implications for Muir-Torre Screening and Classification.
   Am J Ophthalmol. 2026 Feb 18:S0002-9394(26)00079.
   PubMed         Abstract available
   
   

   
   BMC Cancer

9. MOGHADAM A, Gill VT, Sabazade S, Hagstrom A, et al
   Independent validation of time to treatment as a prognostic factor in uveal melanoma.
   BMC Cancer. 2026 Feb 19. doi: 10.1186/s12885-026-15775.
   PubMed        
   
   

   
   Br J Dermatol

10. ZHOU C, Zhao Y, Zhu G, Wu L, et al
    Efficacy and safety of stapokibart in adolescents with moderate-to-severe atopic dermatitis: a multicenter, randomized, double-blind, placebo-controlled phase 3 trial.
    Br J Dermatol. 2026 Feb 16:ljag052. doi: 10.1093.
    PubMed         Abstract available
    
    
11. KIPS J, Papeleu J, Shen A, Mylle S, et al
    Artificial intelligence-based smartphone application for skin cancer detection: A prospective diagnostic accuracy study.
    Br J Dermatol. 2026 Feb 17:ljag057. doi: 10.1093.
    PubMed         Abstract available
    
    
12. DONI SN, Mohammed FS, Mohammed AB, Zewdu FT, et al
    Clinical and patient-reported outcomes of cutaneous leishmaniasis treatment in Ethiopia: A prospective, observational cohort study in two referral hospitals.
    Br J Dermatol. 2026 Feb 17:ljag061. doi: 10.1093.
    PubMed         Abstract available
    
    
13. ZHAO F, Guo Y, Jiao Y, Zou W, et al
    Mitochondrial Metabolism in Neutrophils: Emerging Roles in Inflammatory Skin Diseases.
    Br J Dermatol. 2026 Feb 18:ljag060. doi: 10.1093.
    PubMed         Abstract available
    
    
14. PENG X, Ran Y, Wang S, Zhu Y, et al
    Tumour necrosis factor-like weak inducer of apoptosis (TWEAK) is associated with inflammation and disease severity in pemphigus.
    Br J Dermatol. 2026;194:540-550.
    PubMed         Abstract available
    
    
15. BRADSHAW L, Howells LM, Muller I, Mitchell EJ, et al
    Weekly versus daily bathing for people with eczema: results of the Eczema Bathing online randomized controlled trial.
    Br J Dermatol. 2026;194:450-460.
    PubMed         Abstract available
    
    
16. GUO Z, Luo Z, Zhang S, Yu Y, et al
    Sleep patterns and the risk of psoriatic disease: genetic predisposition and metabonomics.
    Br J Dermatol. 2026;194:489-498.
    PubMed         Abstract available
    
    
17. YANG Y, Zhang J, Zhou S, Chen Q, et al
    Germline and somatic second-hit changes in porokeratosis: comprehensive variant spectrum and genotype-phenotype correlation analysis.
    Br J Dermatol. 2026;194:551-558.
    PubMed         Abstract available
    
    
18. BARBAROT S, Aubert H, Boivin M, Foureau A, et al
    Evaluation of antenatal prebiotic intake in infants at risk of atopy: the double-blind PREGRALL randomized clinical trial.
    Br J Dermatol. 2025 Nov 18:ljaf414. doi: 10.1093.
    PubMed         Abstract available
    
    
19. HIEL MAJ, Tedbirt B, Korte EWH, Bolling MC, et al
    Bullous pemphigoid outcome measurement: a scoping review of outcome heterogeneity and trends in clinical research of treatments.
    Br J Dermatol. 2026;194:429-440.
    PubMed         Abstract available
    
    
20. BA W, Zhang G, Tian X, Sun Z, et al
    Disseminated myofibroblastic papulosis in young individuals - a newly identified entity: a clinicopathological study from a case series of eight patients.
    Br J Dermatol. 2026;194:559-565.
    PubMed         Abstract available
    
    

    
    Cancer

21. LIPSCOMB J, Kimmick GG, Wilson JF, Currey A, et al
    Receipt of guideline-concordant local and chemotherapy-based systemic therapy for patients with triple-negative breast cancer: 10-year survival outcomes in a multi-state population-based analysis.
    Cancer. 2026;132:e70267.
    PubMed         Abstract available
    
    
22. ZAKHARIA Y, Kim D, Freesmeier M, Frees M, et al
    A phase 1b/2 study of cabozantinib in combination with pembrolizumab in advanced cutaneous melanoma.
    Cancer. 2026;132:e70326.
    PubMed         Abstract available
    
    

    
    Cancer Lett

23. XIA F, Zhu X, Li X, Yi Q, et al
    FIG4 Downregulation-Arrested Autophagy-lysosomal Degradation of IL-18 Drives Lipid-Associated Macrophage Polarization and Immunotherapy Resistance in Triple-Negative Breast Cancer.
    Cancer Lett. 2026 Jan 21:218278. doi: 10.1016/j.canlet.2026.218278.
    PubMed         Abstract available
    
    
24. DHRUBA SR, Sahni S, Wang B, Wu D, et al
    Enhanced prediction of breast cancer patient response to chemotherapy by integrating deconvolved expression patterns of immune, stromal and tumor cells.
    Cancer Lett. 2025 Oct 30:218101. doi: 10.1016/j.canlet.2025.218101.
    PubMed         Abstract available
    
    
25. FU Y, Jiang C, Chen Y, Li F, et al
    Pharmacological inhibition of histone deacetylase 6 and DNA damage repair enhances radiosensitivity in melanoma.
    Cancer Lett. 2026 Feb 17:218322. doi: 10.1016/j.canlet.2026.218322.
    PubMed         Abstract available
    
    

    
    Cancer Res

26. YIN S, Liu Y, Guan X, Wang X, et al
    Tetraspanin 13 Enhances Immune Evasion in Breast Cancer by Promoting MHC-I Degradation.
    Cancer Res. 2025 Nov 11. doi: 10.1158/0008-5472.CAN-25-1223.
    PubMed         Abstract available
    
    
27. RONDEAU V, Bansal S, Buttigieg MM, Zeng AGX, et al
    Response to Immune Checkpoint Blockade Is Enhanced in the Presence of Hematopoietic TET2 Inactivation.
    Cancer Res. 2026;86:845-857.
    PubMed         Abstract available
    
    
28. HOFER I, Kieffer Y, Mencattini A, Croizer H, et al
    An Extracellular Matrix-Producing Subset of Cancer-Associated Fibroblasts Drives Chemoresistance in Breast Cancer via SRC Activation and G0S2 Upregulation.
    Cancer Res. 2025 Nov 12. doi: 10.1158/0008-5472.CAN-25-0966.
    PubMed         Abstract available
    
    
29. KRANTZ S, Bell BA, Lund K, Salinas Parra N, et al
    Dissection of Galphas and Hedgehog Signaling Cross-talk Reveals Therapeutic Opportunities to Target Hedgehog-Dependent Tumors.
    Cancer Res. 2026;86:940-953.
    PubMed         Abstract available
    
    

    
    Clin Exp Dermatol

30. HOBAN J, Leahy M, Byrne B, Lynch M, et al
    I was the barrier: A patient's perspective on delayed diagnosis of malignant melanoma.
    Clin Exp Dermatol. 2026 Feb 17:llag079. doi: 10.1093.
    PubMed        
    
    

    
    Int J Dermatol

31. KOUMPRENTZIOTIS IA, Bakella A, Tsimpidakis A, Stratigos A, et al
    Cutaneous Toxicities Associated With Amivantamab in Patients With Non-Small Cell Lung Cancer: A Systematic Review.
    Int J Dermatol. 2026 Feb 18. doi: 10.1111/ijd.70347.
    PubMed        
    
    
32. ZAPPI I, McNeal S, Kim K, Flamm AF, et al
    Exploring Stigma in Visible Skin Disease Through Popular Media: Insights From KPop Demon Hunters.
    Int J Dermatol. 2026 Feb 17. doi: 10.1111/ijd.70332.
    PubMed        
    
    

    
    Intern Med

33. MINEKAWA E, Oto Y, Muro Y, Nishino I, et al
    Acute muscle injury and subcutaneous edema in a patient with anti-nuclear matrix protein-2 antibody positive dermatomyositis sine dermatitis: A Case Report.
    Intern Med. 2026 Feb 17. doi: 10.2169/internalmedicine.6410.
    PubMed         Abstract available
    
    

    
    J Cutan Pathol

34. BATHEJA A, Bai R, Gillam J, Haught J, et al
    Infarcted Melanocytic Nevus With a Hair Tourniquet.
    J Cutan Pathol. 2026 Feb 18. doi: 10.1111/cup.70075.
    PubMed        
    
    

    
    J Dermatol

35. YONEYAMA M, Hagino T, Uchiyama A, Saeki H, et al
    Seventy-Two-Week Real-World Outcomes of Tralokinumab Treatment for Moderate-To-Severe Atopic Dermatitis: Analyses Stratified by Baseline Rash and Itch Severity.
    J Dermatol. 2026 Feb 16. doi: 10.1111/1346-8138.70187.
    PubMed         Abstract available
    
    
36. KUMAGAI H, Ototake Y, Watanabe T, Takamura N, et al
    A Case of Bullous Pemphigoid Coexisted With Psoriasis Vulgaris Successfully Treated by Apremilast.
    J Dermatol. 2026 Feb 16. doi: 10.1111/1346-8138.70189.
    PubMed        
    
    
37. TATENO Y, Nobeyama Y
    Severe Infectious Skin Necrosis on Bilateral Superior Eyelids.
    J Dermatol. 2026 Feb 16. doi: 10.1111/1346-8138.70190.
    PubMed        
    
    
38. IRIE K, Igari S, Endo M, Mukaiyama R, et al
    A Case of Pseudomyogenic Hemangioendothelioma Clinically Mimicking Whitlow With Subsequent Cutaneous Metastasis.
    J Dermatol. 2026 Feb 17. doi: 10.1111/1346-8138.70188.
    PubMed         Abstract available
    
    
39. ADAMS MJ, Garza J, Chong BF
    Lupus Erythematosus Panniculitis Patients With Overlying Discoid Lupus Erythematosus Have Higher Rates of Head and Neck Involvement Than Those Without.
    J Dermatol. 2026 Feb 19. doi: 10.1111/1346-8138.70193.
    PubMed        
    
    
40. OKAMOTO H, Nakamura Y
    Dysbiosis in the Pathogenesis of Atopic Dermatitis.
    J Dermatol. 2026 Feb 20. doi: 10.1111/1346-8138.70191.
    PubMed         Abstract available
    
    

    
    Mycoses

41. PHAN KL, Chandler DJ
    Clinical and Mycological Profile of Dermatophyte Infections in South-East England: A 17-Year Retrospective Analysis (2006-2023).
    Mycoses. 2026;69:e70165.
    PubMed         Abstract available
    
    

    
    N Engl J Med

42. 
    Nivolumab for Resected Stage III or IV Melanoma at 9 Years.
    N Engl J Med. 2026;394:832.
    PubMed        
    
    

    
    PLoS Comput Biol

43. WANG Y, Zang C, Li Z, Guo CC, et al
    A comparative study of statistical methods for identifying differentially expressed genes in spatial transcriptomics.
    PLoS Comput Biol. 2026;22:e1013956.
    PubMed         Abstract available
    
    

    
    PLoS One

44. BOKHARI BT, Saleh AM, Aljohani HM, Owaydhah WH, et al
    System biology and network-based approach to identify the therapeutic signatures and potential inhibitors against polycystic lipomembranous osteodysplasia with Sclerosing Leukoencephalopathy.
    PLoS One. 2026;21:e0343274.
    PubMed         Abstract available
    
    
45. ALQAHTANI S, Alqahtani K, Alshomrani F, AlQahtani K, et al
    AdaptiveInvolutionNet: Spatially-adaptive involution with channel-wise attention for breast MRI tumor classification.
    PLoS One. 2026;21:e0340808.
    PubMed         Abstract available
    
    
46. XU F, Xie S, Li Q, Zhong X, et al
    The effect of self-concealment on post-traumatic stress symptoms in breast cancer patients: The mediating role of experiential avoidance.
    PLoS One. 2026;21:e0342971.
    PubMed         Abstract available
    
    
47. GEBREGIORGIS MA, Berhe A, Gebrehiwot H, Abrha MG, et al
    Prevalence and associated factors of skin disease among school-age children of rural district of eastern zone of Tigray, Ethiopia, 2024.
    PLoS One. 2026;21:e0342768.
    PubMed         Abstract available
    
    
48. ABECK F, Heinen I, Heidrich I, Kott J, et al
    Testing undergraduate medical students' ability to correctly identify skin conditions in skin of color-A pre-post-study at a medical school in Germany.
    PLoS One. 2026;21:e0342922.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

49. YAN P, Bui T, Rojas Jimenez E, Kuang Y, et al
    Aging-associated differences in mammary tumor-initiating populations and immune evasion pathways in breast cancer.
    Proc Natl Acad Sci U S A. 2026;123:e2523254123.
    PubMed         Abstract available
    
    
50. LOU KL, Bai JW, Liu HT, Lin LL, et al
    TROP2-targeted NIR-II fluorescence imaging for visualizing surgical margins and metastatic sentinel lymph nodes in breast cancers.
    Proc Natl Acad Sci U S A. 2026;123:e2519420123.
    PubMed         Abstract available
    
    
51. BAIRD MA, Jewett CE, Malide DA, Kratz L, et al
    Lamin B receptor upregulation in metastatic melanoma causes nuclear envelope fragility in confined migration during cancer invasion.
    Proc Natl Acad Sci U S A. 2026;123:e2513031123.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Dermatology is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum